Previous molecular genetic studies have shown that during programmed c
hromosomal healing, telomerase adds telomeric repeats directly to non-
telomeric sequences in Tetrahymena, forming de novo telomeres. However
, the biochemical mechanism underlying this process is not well unders
tood. Here, we show for the first time that telomerase activity is cap
able in vitro of efficiently elongating completely non-telomeric DNA o
ligonucleotide primers, consisting of natural telomere-adjacent or ran
dom sequences, at low primer concentrations, Telomerase activity isola
ted from mated or vegetative cells had indistinguishable specificities
for nontelomeric and telomeric primers, Consistent with in vivo resul
ts, the sequence GGGGT... was the predominant initial DNA sequence add
ed by telomerase in vitro onto the 3' end of the non-telomeric primers
. The 3' and 5' sequences of the primer both influenced the efficiency
and pattern of de novo telomeric DNA addition, Priming of telomerase
by double-stranded primers with overhangs of various lengths showed a
requirement for a minimal 3' overhang of 20 nucleotides. With fully si
ngle-stranded non-telomeric primers, primer length up to similar to 30
nucleotides strongly affected the efficiency of telomeric DNA additio
n, We propose a model for the primer binding site of telomerase for no
n-telomeric primers to account for these length and structural require
ments, We also propose that programmed de novo telomere addition in vi
vo is achieved through a hitherto undetected intrinsic ability of telo
merase to elongate completely non-telomeric sequences.